<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03436212</url>
  </required_header>
  <id_info>
    <org_study_id>ALMED-17-001</org_study_id>
    <nct_id>NCT03436212</nct_id>
  </id_info>
  <brief_title>Real-Life Home Glucose Monitoring Over 14 Days in T2D Patients With Intensified Therapy Using Insulin Pump.</brief_title>
  <acronym>CLOSE</acronym>
  <official_title>Real-Life Home Glucose Monitoring Over 14 Days in T2D Patients With Intensified Therapy Using Insulin Pump. The CLOSE Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Air Liquide Santé International</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Air Liquide Santé International</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims at describing the glucose level by automated glucose sensors and correlating
      it with insulin delivery and meals over 14 days in insulin-requiring T2D patients living in
      real-life conditions.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 5, 2017</start_date>
  <completion_date type="Anticipated">March 2018</completion_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Relationships between glucose levels and insulin doses</measure>
    <time_frame>14 days</time_frame>
    <description>To describe the relationships between glucose levels and insulin doses between meals and at meal-times in T2D patients using pumps over 14 days.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Type 2 Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Continuous Glucose Monitoring (CGM)</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>DEXCOMG4 device for 14 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Continuous Glucose Monitoring (CGM)</intervention_name>
    <description>DEXCOMG4 device</description>
    <arm_group_label>Continuous Glucose Monitoring (CGM)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Selection criteria:

          -  Type 2 Diabetes diagnosed for at least 5 years

          -  Treated with insulin pump for at least 6 months

          -  7.5% ≤ HBA1c ≤ 10% (last available value dated less than 3 months)

          -  Having given his/her free, express and informed consent to participate to the study

        Inclusion Criteria:

          -  7.5% ≤ HBA1c ≤ 10% (result of the dosage performed at selection visit)

          -  Daily insulin requirement ≤ 1.5U/kg/day

          -  Having been compliant to take pictures of his/her meals and snacks over the 3 days
             prior to the inclusion visit

        Non-selection/Non-inclusion criteria:

          -  Pregnant or breastfeeding woman

          -  Comorbidity which, in the investigator's opinion, could jeopardize the study
             completion

          -  Patient with difficulties to understand the study procedures or deemed unfit, by the
             Investigator, to comply with operating instructions of CGM equipment.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yves Reznik, MD</last_name>
    <role>Study Chair</role>
    <affiliation>CHU Caen</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Renaud Mougenot</last_name>
    <phone>+33 1 39 07 20 68</phone>
    <email>renaud.mougenot@airliquide.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Guila Lancman</last_name>
    <phone>+33 1 39 07 62 86</phone>
    <email>guila.lancman@airliquide.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU de Caen, Service Endocrinologie, Diabétologie</name>
      <address>
        <city>Caen</city>
        <zip>14033</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yves Reznik, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 12, 2018</study_first_submitted>
  <study_first_submitted_qc>February 12, 2018</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 16, 2018</study_first_posted>
  <last_update_submitted>February 12, 2018</last_update_submitted>
  <last_update_submitted_qc>February 12, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 16, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

